NorthWest Biotherapeutics Inc (NWBO)

[Troymister]

All probably true--but it still reflects a very poor communications strategy. Presentation at a science conference should have occurred after (shortly after or nearly simultaneous) to publication in a science journal and a PR release...not the other way around where the company is curtailed on what it can say or do.

The shorts had their way today and who knows how many tens of millions of shares big pharma purchased at less than $1 per share?

Congratulations to the scientists who have pursued what appears to be a remarkable advance in treatment of a terrible cancer. A Bronx cheer to management for the way it has handled communications. Again.